Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month Open-Label Extension
Authors:
- Viktor SamokhvalovVSViktor Samokhvalov
- Michelle KramerMKMichelle Kramer
- Lisa FordLFLisa Ford
- Cristiana Gassmann-MayerCGCristiana Gassmann-Mayer
- Pilar LimPLPilar Lim
- Mariëlle EerdekensMEMariëlle Eerdekens
- 1 January 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 16 (1) , 31-43
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial☆Schizophrenia Research, 2007
- Paliperidone Extended-Release Tablets for Prevention of Symptom Recurrence in Patients With SchizophreniaJournal of Clinical Psychopharmacology, 2007
- Evidence-Based Review of Pharmacologic and Nonpharmacologic Treatments for Older Adults with SchizophreniaPsychiatric Clinics of North America, 2005
- Treatment of Schizophrenia With Long-Acting Injectable RisperidoneThe Journal of Clinical Psychiatry, 2003
- Binding of antipsychotic drugs to human brain receptorsLife Sciences, 2000
- Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioningActa Psychiatrica Scandinavica, 2000
- Risperidone in the ElderlyThe Journal of Clinical Psychiatry, 1997
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970
- Estimates of Location Based on Rank TestsThe Annals of Mathematical Statistics, 1963